AstraZeneca's troubles with its Covid-19 vaccine are not over yet
May 13, 2024
Washington [USA], may 13: The European Commission recently announced the termination of circulation of AstraZeneca 's Covid-19 Vaxzevria vaccine from May 7. Previously, according to The Conversation , AstraZeneca filed an application on March 27 to terminate the circulation license of this vaccine in European Union (EU) member countries. AstraZeneca said it will also proactively coordinate with country management agencies to terminate Vaxzevria's marketing authorization when there is no longer a need for use.
